Title : Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance).

Pub. Date : 2021 Jul 13

PMID : 34251414






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In a phase 1 study of AML patients treated with G3139, cytarabine, and daunorubicin induction with cytarabine consolidation, no antisense-related toxicity was reported, and BCL2 downregulation occurred in patients achieving complete remission. Daunorubicin BCL2 apoptosis regulator Homo sapiens